News summaryThe Motley FoolNov 3, 2026, 01:30 PM
Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
Pfizer reported third-quarter revenue of $16.6 billion, above analyst expectations of $15.9 billion. [[fact:fact-9srxk423d]] Adjusted earnings were 87 cents per share, exceeding Wall Street estimates of 73 cents. [[fact:fact-xod1cdw4f]] The company raised its full-year adjusted earnings guidance to $2.95–$3.05 per share from $2.80–$3. [[fact:fact-96osk75n0]] Revenue from launched and acquired products rose 32% in the quarter. [[fact:fact-4ob8085ur]]